Figure 2. Flow chart of management, both primary and secondary prevention, in the context of lupus erythematosus (LE). ACEi, ACE inhibitor; ARB, angiotensin receptor blocker; ASCVD, atherosclerotic cardiovascular disease. Updated with permission from Keyes et al.⁵.